Biotech »

Bellus, Auven enter licence agreement for Kiacta

Bellus, Auven enter licence agreement for Kiacta

Alpha Stox May 2, 2014 Comments Off

Ms. Kathy Armstrong of Auven reports AUVEN THERAPEUTICS AND BELLUS HEALTH ANNOUNCE LICENCE AGREEMENT WITH MOUNT SINAI FOR KIACTA(TM) IN SARCOIDOSIS Auven Therapeutics and Bellus Health Inc. have entered into a licence agreement with

Read More »
Charles Duncan: 2014 Is for Careful Stock Pickers, Not Dart Throwers

Charles Duncan: 2014 Is for Careful Stock Pickers, Not Dart Throwers

Alpha Stox April 29, 2014 Comments Off

Source: George S. Mack of The Life Sciences Report (4/24/14) Charles Duncan Veteran Senior Biotechnology Analyst Charles Duncan of Piper Jaffray & Co. sees platform companies as the perfect way to play a consolidating

Read More »
Do the Math: Ram Selvaraju on the Appeal of Biotechs in Orphan Diseases

Do the Math: Ram Selvaraju on the Appeal of Biotechs in Orphan Diseases

Alpha Stox April 29, 2014 Comments Off

Source: George S. Mack of The Life Sciences Report (4/22/14) To cast a spotlight on disruptive biotechnology stocks, Raghuram “Ram” Selvaraju of Aegis Capital Corp. taps his experience as a molecular biologist, preclinical investigator

Read More »
Newsletterpopup_top_1

Your Name (required)

Your Email (required)

captcha

Newsletterpopup_bottom_1